2021 |
04/20 | 300 | 301 | 297 | 300 | -1.32% | 109,700 | 87億9159万 | -0.33% |
04/19 | 300 | 305 | 296 | 304 | +3.05% | 164,400 | 89億881万 | +1% |
04/19 | 8:30 炎症系、中枢系疾患を対象にしたAIを用いた新規のキナーゼ阻害剤の創製に関する共同創薬のお知らせ |
04/16 | 294 | 296 | 293 | 295 | +0.34% | 27,500 | 86億4506万 | -1.99% |
04/15 | 16:45 譲渡制限付株式報酬としての新株式発行に関するお知らせ |
04/15 | 294 | 297 | 292 | 294 | -1.01% | 47,900 | 86億1575万 | -2.33% |
04/14 | 298 | 298 | 291 | 297 | 0% | 49,500 | 87億367万 | -1.33% |
04/13 | 298 | 298 | 295 | 297 | 0% | 33,200 | 87億367万 | -1.33% |
04/12 | 300 | 300 | 292 | 297 | -0.34% | 109,000 | 87億367万 | -1.33% |
04/09 | 295 | 299 | 295 | 298 | 0% | 51,200 | 87億3297万 | -1% |
04/08 | 300 | 300 | 297 | 298 | -0.67% | 56,000 | 87億3297万 | -1% |
04/07 | 304 | 304 | 298 | 300 | -1.32% | 46,800 | 87億9159万 | 0% |
04/06 | 302 | 304 | 298 | 304 | +1% | 69,500 | 89億881万 | +1.33% |
04/05 | 302 | 303 | 300 | 301 | -0.33% | 52,300 | 88億2089万 | +0.33% |
04/02 | 302 | 305 | 301 | 302 | -0.66% | 26,100 | 88億5020万 | +1% |
04/01 | 302 | 306 | 302 | 304 | +0.66% | 34,900 | 89億881万 | +1.67% |
03/31 | 301 | 305 | 300 | 302 | -0.33% | 40,900 | 88億5020万 | +1% |
03/30 | 299 | 303 | 299 | 303 | +1.68% | 43,300 | 88億7950万 | +1.34% |
03/29 | 305 | 306 | 298 | 298 | -2.3% | 65,400 | 87億3297万 | -0.33% |
03/26 | 303 | 306 | 302 | 305 | +0.33% | 38,600 | 89億3811万 | +2.01% |
03/25 | 297 | 304 | 297 | 304 | +1.33% | 82,100 | 89億881万 | +1.67% |
03/24 | 305 | 305 | 297 | 300 | -1.64% | 112,100 | 87億9159万 | +0.33% |
03/23 | 303 | 313 | 303 | 305 | +0.66% | 154,800 | 89億3811万 | +2.01% |
03/22 | 305 | 312 | 302 | 303 | -0.66% | 149,700 | 88億7950万 | +1.34% |
03/19 | 305 | 307 | 302 | 305 | -1.29% | 67,700 | 89億2158万 | +1.33% |
03/18 | 303 | 309 | 303 | 309 | +1.31% | 81,000 | 90億3858万 | +2.32% |
03/17 | 301 | 305 | 300 | 305 | +0.66% | 66,400 | 89億2158万 | +0.66% |
03/16 | 302 | 304 | 300 | 303 | +0.66% | 41,100 | 88億6308万 | -0.66% |
03/15 | 298 | 302 | 296 | 301 | +1.01% | 94,000 | 88億458万 | -1.95% |
03/12 | 297 | 306 | 292 | 298 | +0.34% | 148,200 | 87億1682万 | -3.25% |
03/11 | 300 | 300 | 295 | 297 | 0% | 37,200 | 86億8757万 | -4.19% |
03/10 | 297 | 300 | 294 | 297 | +0.34% | 62,200 | 86億8757万 | -4.5% |
03/09 | 291 | 296 | 286 | 296 | +2.42% | 60,100 | 86億5832万 | -5.13% |
03/08 | 288 | 295 | 287 | 289 | +1.4% | 82,900 | 84億5356万 | -7.67% |
03/05 | 288 | 289 | 280 | 285 | -1.04% | 157,100 | 83億3656万 | -9.52% |
03/04 | 293 | 293 | 285 | 288 | -2.7% | 180,600 | 84億2431万 | -9.15% |
03/03 | 297 | 297 | 293 | 296 | -0.34% | 48,500 | 86億5832万 | -6.92% |
03/02 | 295 | 300 | 293 | 297 | +1.02% | 82,600 | 86億8757万 | -7.19% |
03/01 | 15:30 第10回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
03/01 | 295 | 298 | 293 | 294 | -0.34% | 69,900 | 85億9982万 | -8.41% |
02/26 | 300 | 300 | 293 | 295 | -1.99% | 131,900 | 86億2907万 | -8.39% |
02/25 | 300 | 303 | 300 | 301 | +1.01% | 41,800 | 88億458万 | -6.81% |
02/24 | 301 | 307 | 298 | 298 | -1% | 115,500 | 87億1682万 | -8.02% |
02/22 | 299 | 305 | 299 | 301 | +0.67% | 87,900 | 88億458万 | -7.1% |
02/19 | 309 | 309 | 298 | 299 | -1.97% | 103,500 | 87億4607万 | -8% |
02/18 | 311 | 313 | 305 | 305 | -2.56% | 65,600 | 89億2158万 | -6.15% |
02/17 | 298 | 313 | 298 | 313 | +5.03% | 118,000 | 91億5559万 | -3.4% |
02/16 | 306 | 307 | 297 | 298 | -3.25% | 198,700 | 87億1682万 | -8.02% |
02/15 | 325 | 328 | 307 | 308 | -9.14% | 431,800 | 90億933万 | -4.94% |
02/12 | 15:30 2020年12月期決算短信〔日本基準〕(連結) |
02/12 | 15:30 2020年12月期通期決算説明資料 |
02/12 | 339 | 341 | 331 | 339 | -1.17% | 130,800 | 99億1612万 | +4.95% |
02/10 | 341 | 344 | 331 | 343 | +0.59% | 150,400 | 100億3312万 | +6.85% |
02/09 | 345 | 348 | 340 | 341 | -0.58% | 103,600 | 99億7462万 | +7.23% |
02/08 | 350 | 350 | 339 | 343 | -2% | 209,100 | 100億3312万 | +8.54% |
02/05 | 337 | 350 | 333 | 350 | +5.11% | 239,800 | 102億3788万 | +11.46% |
02/04 | 332 | 336 | 331 | 333 | -0.6% | 56,000 | 97億4061万 | +7.07% |
02/03 | 328 | 338 | 328 | 335 | +0.9% | 123,500 | 97億9911万 | +8.41% |
02/02 | 328 | 332 | 322 | 332 | +1.22% | 48,700 | 97億1136万 | +8.14% |
02/01 | 320 | 328 | 313 | 328 | +1.86% | 80,400 | 95億9436万 | +7.54% |
01/29 | 326 | 333 | 321 | 322 | -2.13% | 125,400 | 94億1885万 | +6.62% |
01/28 | 325 | 331 | 323 | 329 | -0.6% | 73,600 | 96億2361万 | +9.3% |
01/27 | 327 | 333 | 327 | 331 | +0.3% | 71,400 | 96億8211万 | +10.7% |
01/26 | 333 | 335 | 326 | 330 | -1.79% | 124,800 | 96億5286万 | +11.11% |
01/25 | 325 | 336 | 323 | 336 | +3.38% | 197,000 | 98億2836万 | +13.51% |
01/22 | 323 | 325 | 321 | 325 | +0.31% | 83,700 | 95億660万 | +10.54% |
01/21 | 321 | 325 | 320 | 324 | +1.25% | 120,700 | 94億7735万 | +10.58% |
01/20 | 331 | 331 | 318 | 320 | +1.59% | 259,200 | 93億6035万 | +9.59% |
01/20 | 8:45 眼科手術補助剤「DW-1002」のカナダにおける承認取得のお知らせ |
01/19 | 307 | 317 | 306 | 315 | +2.61% | 93,500 | 92億1409万 | +8.25% |
01/18 | 311 | 312 | 300 | 307 | -0.65% | 78,600 | 89億8008万 | +5.5% |
01/15 | 297 | 309 | 297 | 309 | +4.04% | 303,900 | 90億3858万 | +6.55% |
01/14 | 15:30 業績予想の修正に関するお知らせ |
01/14 | 297 | 300 | 296 | 297 | -0.34% | 54,900 | 86億8757万 | +2.41% |
01/13 | 301 | 304 | 298 | 298 | 0% | 79,300 | 87億1682万 | +2.41% |
01/12 | 297 | 301 | 294 | 298 | +1.02% | 158,400 | 87億1682万 | +2.05% |
01/08 | 286 | 296 | 286 | 295 | +2.79% | 105,900 | 86億2907万 | +0.68% |
01/07 | 293 | 293 | 286 | 287 | -1.37% | 71,200 | 83億9506万 | -2.38% |
01/06 | 282 | 292 | 282 | 291 | +3.19% | 103,600 | 85億1207万 | -1.36% |
01/05 | 281 | 286 | 279 | 282 | -1.05% | 95,400 | 82億4881万 | -5.05% |
01/04 | 289 | 289 | 280 | 285 | -1.38% | 118,500 | 83億3656万 | -4.68% |
2020 |
12/30 | 280 | 290 | 280 | 289 | +2.12% | 216,200 | 84億5356万 | -3.99% |
12/29 | 270 | 283 | 269 | 283 | +4.43% | 179,700 | 82億7806万 | -6.29% |
12/28 | 276 | 278 | 268 | 271 | -2.87% | 387,900 | 79億2704万 | -10.86% |
12/25 | 280 | 285 | 278 | 279 | -1.06% | 175,300 | 81億6105万 | -8.82% |
12/24 | 276 | 287 | 275 | 282 | +2.55% | 265,300 | 82億4881万 | -8.44% |
12/23 | 276 | 282 | 275 | 275 | -1.08% | 209,200 | 80億4405万 | -11.29% |
12/22 | 284 | 286 | 278 | 278 | -3.47% | 213,900 | 81億3180万 | -10.9% |
12/21 | 290 | 292 | 285 | 288 | -1.37% | 161,400 | 84億2431万 | -8.28% |
12/18 | 290 | 295 | 286 | 292 | +0.34% | 173,600 | 85億4132万 | -7.3% |
12/17 | 296 | 297 | 290 | 291 | -1.02% | 211,800 | 85億1207万 | -8.2% |
12/16 | 299 | 300 | 292 | 294 | -1.67% | 177,400 | 85億9982万 | -7.55% |
12/15 | 301 | 303 | 298 | 299 | -0.99% | 64,400 | 87億4607万 | -6.27% |
12/14 | 299 | 307 | 297 | 302 | +1.68% | 132,000 | 88億3383万 | -5.63% |
12/11 | 292 | 298 | 292 | 297 | +0.34% | 142,300 | 86億8757万 | -7.48% |
12/10 | 297 | 301 | 296 | 296 | -1.33% | 84,000 | 86億5832万 | -8.07% |
12/09 | 304 | 305 | 295 | 300 | -2.6% | 270,000 | 87億7533万 | -7.41% |
12/08 | 311 | 312 | 303 | 308 | -1.28% | 177,900 | 90億933万 | -4.94% |
12/07 | 320 | 321 | 312 | 312 | -2.19% | 207,200 | 91億2634万 | -4% |
12/04 | 321 | 324 | 318 | 319 | -0.62% | 98,500 | 93億3110万 | -1.85% |
12/03 | 324 | 326 | 320 | 321 | -1.23% | 105,600 | 93億8960万 | -1.53% |
12/02 | 321 | 327 | 321 | 325 | +0.31% | 71,800 | 95億660万 | -0.31% |
12/01 | 324 | 327 | 320 | 324 | -1.22% | 151,800 | 94億7735万 | -0.61% |
11/30 | 15:30 ファシリティ契約に基づく第10回新株予約権(行使価額修正条項付)の行使停止要請通知に関するお知らせ |
11/30 | 331 | 334 | 328 | 328 | -0.91% | 57,000 | 95億9436万 | +0.31% |
11/27 | 327 | 333 | 327 | 331 | +0.61% | 132,600 | 96億8211万 | +1.22% |
11/26 | 331 | 331 | 328 | 329 | 0% | 55,800 | 96億2361万 | +0.61% |
11/25 | 332 | 335 | 327 | 329 | -1.5% | 108,300 | 96億2361万 | +0.3% |